Clinical Trial Update: Clearing Lungs With Epithelial Sodium Channel (ENaC) Inhibition in Cystic Fibrosis (CF) [Phase 2]

View source ↗

Summary

Phase 2 trial investigating ENaC inhibition to clear lungs in cystic fibrosis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cystic Fibrosis

Snippet

Sponsor: Parion Sciences | Conditions: Cystic Fibrosis | Phase 2 | Status: COMPLETED